Discover the importance of chelation in medical science in this informative article. Learn about its benefits and applications.

Chelation therapy is a medical treatment technique aimed at removing heavy metals and toxins from the body. The term “chelation” comes from the Greek word “chele,” meaning claw, in reference to the unique ability of certain compounds to bind strongly to heavy metals and eliminate them from the body through urine or feces. In this therapy, a chelating agent, usually administered by intravenous infusion, is used to effectively bind to heavy metals and facilitate their excretion.

This therapy has been used for decades as a conventional treatment for heavy metal poisoning, mainly caused by lead, mercury and arsenic. Chelation therapy works by chemically binding to these toxic metals in the bloodstream, forming a stable complex that can be easily eliminated from the body. Aside from heavy metal poisoning, chelation therapy is also being studied as a possible treatment for other conditions, such as cardiovascular disease, thanks to its ability to remove excess calcium from the arteries and improve blood circulation.

The US Food and Drug Administration (FDA) has approved chelation therapy for the treatment of lead poisoning and toxicity caused by other heavy metals. However, its use for conditions other than heavy metal poisoning is considered off-label and requires careful evaluation and consultation with a qualified healthcare professional.

The chelating agents used in this treatment are ethylenediaminetetraacetic acid (EDTA), dimercaptosuccinic acid (DMSA) and dimercaprol (BAL). These agents form stable complexes with heavy metals, preventing them from causing further damage to tissues and organs. Additionally, some chelating agents, such as EDTA, have antioxidant properties that can help reduce oxidative stress in the body.

1. Chelation therapy is administered primarily by intravenous infusion to ensure proper absorption and distribution of chelating agents in the body.
2. The duration and frequency of chelation sessions may vary depending on the condition of each person and the goals of the treatment.
3. During therapy, patients may experience mild side effects such as headache, fatigue and gastrointestinal alterations.

What is the quelation? What is it and how it works

A Primer on Chelating Agents

How chelating agents act

Chelating agents act forming a stable complex with metal ions, capturing them and effectively eliminating them from the organism. When chelating agents are administered, metal ions are bound selectively, forming a coordination complex. The resulting complex is usually hydrosoluble, which facilitates its excretion through urine or feces. This process prevents metal ions from reacting with other biomolecules, minimizing their harmful effects on the body.

Chelating agents have been used for decades to treat heavy metal poisoning, such as lead or mercury, as well as certain types of cancer.

Types of chelating agents

Chelating agents can be classified into two main types: organic and inorganic chelants. Organic chelants, such as ethylendiaminoteracetic acid (EDTA) or dimercaptosuccin acid (DMSA), contain carbon in their molecular structure. They are widely used in clinical environments due to their ability to bother a wide range of metal ions. Inorganic chelants, meanwhile, do not contain carbon and include compounds such as sodium hexametaphosphate or sodium tripoliphosphate, usually used in water treatment to control metal ions.

• Organic chelants
• Inorganic Quelantes

The Science Behind Chelating Agents

Quelation is a process in which a chelating agent joins metal ions, forming a stable and soluble complex. This complex helps eliminate toxic metals from the organism, as well as control its activity and distribution. Quelation therapy has demonstrated its usefulness in several diseases, such as heavy metal poisoning, renal dysfunction and iron overload disorders. Understanding the science behind chelars can shed light on their therapeutic potential and their mechanisms of action.

Quelante agents: chemical compounds that form coordination complexes with metal ions.

1. Metal ion union: chelating agents have functional groups or ligands that have solitary electron pairs. These lonely pairs form covalent bonds with metal ions, surrounding them and immobilizing them. This prevents metal ions from interacting with other molecules and causing harmful effects.
2. Stability and solubility: The complexes formed by quelation are highly stable, preventing the dissociation of metal ions and guaranteeing their secure elimination of the organism. In addition, chelating agents increase the solubility of metal ions, helping their excretion through urine or feces.
3. Specificity: chelating agents have preferential binding affinities towards certain metal ions. This selectivity allows directed therapy, in which specific chelants can be used to selectively eliminate concrete metals, at the same time minimizing interference with essential biological ions.

The use of chelating agents in medical applications requires careful consideration of factors such as dose, route of administration and possible side effects. In addition, the development and optimization of chelants with greater specificity and efficiency remain an active research area. The science that underlies chelating agents feels the foundations for their therapeutic use and the advances that are taking place in this field.

Applications of Chelating in Environmental Cleanup

Quelante agents in soil recovery: one of the key applications of chelating agents in environmental cleaning is soil recovery. Contaminated soils usually contain high concentrations of heavy metals, which represent a risk for both human health and ecosystems. Quelants can be used to immobilize these metals, preventing their leaching to groundwater or their absorption by plants. By forming soluble complexes with heavy metals, chelating agents facilitate their elimination from the soil through processes such as washing or extraction.

Main advantages of chelating agents in soil recovery:

• Increased bioavailability of pollutants
• Leaching reduction and mobility of heavy metals
• Greater efficacy of soil washing and extraction techniques
• Minimization of secondary pollution

Quelants in water treatment: chelants also have a wide application in water treatment, especially for the elimination of heavy metal contaminants. These agents can be added to water treatment systems to form stable complexes with heavy metals, kidnapping them effectively and preventing their release to the environment. Quelation technology has been used successfully in the treatment of industrial wastewater, mining runoff and contaminated groundwater.

Main advantages of chelating agents in water treatment:

1. Selective union to specific heavy metal ions
2. Greater efficacy for removal of metal ions compared to traditional methods
3. Lower risk of recontamination during treatment
4. Ability to act on a wide range of metal pollutants.

In summary, the applications of chelating agents in environmental cleaning, such as soil recovery and water treatment, offer promising solutions to mitigate pollution and protect ecosystems. The use of chelants provides an effective and selective elimination of heavy metals and other toxic substances, reducing the risks of contaminated soils and waters for human health and the environment.

Chelating in Industrial Processes and Product Development

A key application of chelating agents in industrial processes is their use in the cleanliness and discouragement of metals. Metal surfaces, especially those used in manufacturing and industrial environments, usually accumulate mineral deposits, oxide or unwanted coatings. Chelating agents can effectively join these pollutants, forming water soluble complexes that can be easily washed. The capacity of chelants to selectively address metal ions without affecting the underlying metal surface makes them very effective and profitable for cleaning applications.

In addition to metal cleaning, chelating agents are widely used in the development of products in various industries.

The development of products in industries such as pharmaceuticals, personal care and food and drinks depends largely on chelating agents to improve stability, increase efficacy and prolong useful life. Quelants are used to avoid oxidation and protect sensitive ingredients from degradation. When the metal ions that act as catalysts of oxidation reactions, chelating agents can avoid the formation of harmful free radicals and prolong the useful life of the products.

• Table 1: Common chelating agents used in industrial processes

chelating agent	Applications
Ethylendiaminoteraacetic acid (EDTA)	Metal cleaning, catalysis, pharmaceutical formulations
Nitrilotiacetic acid (NTA)	Wastewater treatment, textile industry, agriculture
Dietethyntriaminopeaacetic acid (DTPA)	Quelation therapy, detergents, food and drinks

Quelation therapy, a medical procedure that implies the administration of chelars to eliminate toxic metals from the organism, has become an established treatment for heavy metal poisoning. However, it is important to keep in mind that the use of quelation therapy is strictly regulated and should only be done under medical supervision. Chelating agents used in this therapy, such as EDTA and DTPA, form stable complexes with toxic metals, facilitating their excretion through urine or feces.

1. Quelation therapy should only be administered by qualified medical professionals in appropriate clinical environments.
2. It is essential to take into account the possible side effects and the risks associated with quelation therapy before undergoing treatment.

In general, chelating agents play an indispensable role in industrial processes and product development by facilitating metal elimination, improving stability and protecting valuable compounds from degradation, which makes them essential tools in various industries.

The Role of Chelating in Medical and Pharmaceutical Fields

In the medical and pharmaceutical fields, chelants play a crucial role in the treatment of various conditions and diseases caused or aggravated by the toxicity of heavy metals. It is known that heavy metals such as lead, mercury, arsenic and cadmium accumulate in the body over time, causing a series of health problems such as organic damage, neurological disorders and cardiovascular problems.

Quelation therapy has been used for decades as a treatment option for heavy metal poisoning, especially in cases where traditional methods, such as support and detoxification care, are insufficient.

1. Quelation therapy works by administering chelants orally or intravenously, which bind to the toxic metals of the organism.
2. Once united, chelating agents form stable complexes with metals, allowing them to excrete them through urine or feces.
3. This process effectively reduces the concentration of toxic metals in the body and helps to relieve associated health symptoms and complications.

The use of quelation therapy goes beyond the treatment of acute poisoning by heavy metals. It is also promising for the treatment of chronic diseases such as cardiovascular, neurodegenerative and some types of cancer. Researchers are exploring the potential of chelars to attack specific metal ions that contribute to the progression of the disease and develop specific therapies.

In general, the quelation plays an important role in the medical and pharmaceutical fields by providing a specific approach to treat the toxicity of heavy metals and associated conditions. Ongoing research and advances in quelation therapy contain immense potential to improve patient results and expand the treatment options of various diseases.

Environmental Impact and Challenges Associated with Chelating

One of the main concerns about the use of chelating agents is their potential to accumulate in the environment and cause lon g-term contamination. Chelating agents, such as ethylendiaminetetraacetic acid (EDTA) and dieth y-centrybentaacetic acid (DTPA), are often used to treat metal contaminated soils or masses. These agents form stable complexes with metal ions, facilitating their elimination or kidnapping. However, if they are not properly managed, these complexes can be filtered to the surrounding environment and persist for long periods, with the consequent potential impact on ecosystems and human health.

• Chelating agents can contribute to the contamination of water masses, especially when used in large quantities for industrial purposes or in agriculture.
• Inadequate elimination of chelate-metallic complexes can cause the accumulation of toxic metals in the soils, affecting the growth of plants and being able to enter the food chain.
• The persistence of chelating agents in the environment can disturb the natural processes of the metal cycle and alter the balance of essential trace metals in ecosystems.

Key challenge: Develop chelating agents respectful of environment that are effective in metal recovery but have reduced persistence and bioaccumulation potential.

To deal with these environmental challenges, researchers and industry are actively exploring alternative agents with greater biodegradability and less toxicity. These efforts are intended to minimize the lon g-term impact of chelating agents on ecological systems and human health, while maintaining their effectiveness in metal recovery. In addition, to reduce the environmental footprint of chelating agents, it is essential to apply waste management practices and appropriate regulations for use and elimination.

1. Research focus: identification and evaluation of the destination and environmental behavior of different chelars to assess their potential risks and design effective mitigation strategies.
2. Regulatory measures: establish guidelines and regulations on the use, storage and elimination of chelating agents to avoid indiscriminate liberation to the environment.
3. Innovation and development: Invest in research and development efforts to create more sustainable and environmentally respectful agents that are effectively join the metal ions minimizing their impacts.

LikeDislike

Author of the article

Dr.Greenblatt M.

Medical oncologist at the Robert Larner College of Medicine, MD, at the University of Vermont